
Jennifer I. Thissell
Examiner (ID: 4322)
| Most Active Art Unit | 3635 |
| Art Unit(s) | 3635 |
| Total Applications | 376 |
| Issued Applications | 300 |
| Pending Applications | 27 |
| Abandoned Applications | 49 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17256754
[patent_doc_number] => 20210369739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => COMBINATION THERAPY OF ACYLTHIOUREA COMPOUND AND ABIRATERONE
[patent_app_type] => utility
[patent_app_number] => 17/277090
[patent_app_country] => US
[patent_app_date] => 2019-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17277090
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/277090 | COMBINATION THERAPY OF ACYLTHIOUREA COMPOUND AND ABIRATERONE | Sep 17, 2019 | Pending |
Array
(
[id] => 17399482
[patent_doc_number] => 20220041572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => CYCLOHEPTYL ACIDS AS LPA ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/276178
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276178
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/276178 | CYCLOHEPTYL ACIDS AS LPA ANTAGONISTS | Sep 15, 2019 | Abandoned |
Array
(
[id] => 17123538
[patent_doc_number] => 20210298306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => PESTICIDALLY ACTIVE AZOLE-AMIDE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/275902
[patent_app_country] => US
[patent_app_date] => 2019-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275902
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/275902 | PESTICIDALLY ACTIVE AZOLE-AMIDE COMPOUNDS | Sep 11, 2019 | Abandoned |
Array
(
[id] => 17343563
[patent_doc_number] => 20220009894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/289709
[patent_app_country] => US
[patent_app_date] => 2019-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 1372
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289709
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/289709 | 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Sep 11, 2019 | Abandoned |
Array
(
[id] => 17399539
[patent_doc_number] => 20220041629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => ESTROGEN RECEPTOR TARGETING ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/275860
[patent_app_country] => US
[patent_app_date] => 2019-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275860
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/275860 | ESTROGEN RECEPTOR TARGETING ANTAGONISTS | Sep 10, 2019 | Pending |
Array
(
[id] => 17413984
[patent_doc_number] => 20220048888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => PYRIMIDINYL-HETEROARYLOXY-NAPHTHYL COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/275609
[patent_app_country] => US
[patent_app_date] => 2019-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275609
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/275609 | PYRIMIDINYL-HETEROARYLOXY-NAPHTHYL COMPOUNDS AND METHODS OF USE | Sep 10, 2019 | Pending |
Array
(
[id] => 17200052
[patent_doc_number] => 20210340147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => 2,6-DIMETHYL-N-((PYRIDlN-4-YL)METHYL)IMIDAZO[1,2-B]PYRIDAZIN-8-AMINE AND 2,5-DIMETHYL-N-[(PYRIDlN-4-YL)METHYL]PYRAZOLO[1,5-A]PYRIMIDlN-7-AMINE DERIVATIVES FOR TREATING VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/282064
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9621
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/282064 | 2,6-dimethyl-n-((pyridin-4-yl)methyl)imidazo[1,2-b]pyridazin-8-amine and 2,5-dimethyl-n-[(pyridin-4-yl)methyl]pyrazolo[1,5-a]pyrimidin-7-amine derivatives for treating viral infections | Aug 19, 2019 | Issued |
Array
(
[id] => 17154835
[patent_doc_number] => 20210315886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => IMIDAZOTETRAZINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/266770
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266770
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/266770 | IMIDAZOTETRAZINE COMPOUNDS | Aug 8, 2019 | Pending |
Array
(
[id] => 17828367
[patent_doc_number] => 20220265671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => METHOD FOR TREATING STROKE BY USING TRICYCLIC DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/630700
[patent_app_country] => US
[patent_app_date] => 2019-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630700
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/630700 | METHOD FOR TREATING STROKE BY USING TRICYCLIC DERIVATIVE | Jul 28, 2019 | Abandoned |
Array
(
[id] => 17214391
[patent_doc_number] => 20210347728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => 4,5-DIHYDROXY-2-(4-METHYLBENZYL)ISOPHTHALONITRILE SOLVATES AND CRYSTALLINE FORMS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/262249
[patent_app_country] => US
[patent_app_date] => 2019-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262249
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/262249 | 4,5-DIHYDROXY-2-(4-METHYLBENZYL)ISOPHTHALONITRILE SOLVATES AND CRYSTALLINE FORMS THEREOF | Jul 23, 2019 | Abandoned |
Array
(
[id] => 19777361
[patent_doc_number] => 12226381
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Composition of fused tricyclic gamma-amino acid derivatives and the preparation thereof
[patent_app_type] => utility
[patent_app_number] => 17/259757
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 16804
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259757
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/259757 | Composition of fused tricyclic gamma-amino acid derivatives and the preparation thereof | Jul 11, 2019 | Issued |
Array
(
[id] => 17170279
[patent_doc_number] => 20210323949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => COMPOUNDS AND METHODS FOR INHIBITION OF MULTIPLE MYELOMA
[patent_app_type] => utility
[patent_app_number] => 17/272135
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17272135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/272135 | COMPOUNDS AND METHODS FOR INHIBITION OF MULTIPLE MYELOMA | Jun 27, 2019 | Abandoned |
Array
(
[id] => 17791936
[patent_doc_number] => 20220251027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => BENZIDINE COMPOUND AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/438067
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438067
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/438067 | Benzidine compound and application thereof | Jun 4, 2019 | Issued |
Array
(
[id] => 16868399
[patent_doc_number] => 20210161866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => DRUG FOR USE IN COMBINATION, AND USE THEREOF FOR PREPARING DRUGS FOR TREATMENT OF HIGH-GRADE BRAIN TUMORS IN RESPONSE TO INEFFECTIVE STANDARD TREATMENT FOR POSTOPERATIVE RECURRENCE
[patent_app_type] => utility
[patent_app_number] => 17/053037
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17053037
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/053037 | DRUG FOR USE IN COMBINATION, AND USE THEREOF FOR PREPARING DRUGS FOR TREATMENT OF HIGH-GRADE BRAIN TUMORS IN RESPONSE TO INEFFECTIVE STANDARD TREATMENT FOR POSTOPERATIVE RECURRENCE | Apr 29, 2019 | Abandoned |
Array
(
[id] => 19969623
[patent_doc_number] => 12338214
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Bexarotene derivatives and their use in treating cancer
[patent_app_type] => utility
[patent_app_number] => 16/971736
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11573
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971736
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/971736 | Bexarotene derivatives and their use in treating cancer | Feb 28, 2019 | Issued |
Array
(
[id] => 17472412
[patent_doc_number] => 20220079916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => USE OF GERANYLFLAVONE A IN PREPARATION OF DRUG FOR PROMOTING HEALING OF WOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/425608
[patent_app_country] => US
[patent_app_date] => 2019-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425608
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/425608 | USE OF GERANYLFLAVONE A IN PREPARATION OF DRUG FOR PROMOTING HEALING OF WOUNDS | Jan 23, 2019 | Abandoned |
Array
(
[id] => 16824204
[patent_doc_number] => 20210139497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => THIENOCYCLIC COMPOUND AND SYNTHESIS METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/767034
[patent_app_country] => US
[patent_app_date] => 2018-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12728
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 366
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767034
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/767034 | THIENOCYCLIC COMPOUND AND SYNTHESIS METHOD THEREFOR AND APPLICATION THEREOF | Nov 22, 2018 | Pending |
Array
(
[id] => 19246771
[patent_doc_number] => 20240197755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => Pharmaceutical composition for use in the therapeutic treatment of cancer and complications of cancer
[patent_app_type] => utility
[patent_app_number] => 16/324881
[patent_app_country] => US
[patent_app_date] => 2017-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16324881
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/324881 | Pharmaceutical composition for use in the therapeutic treatment of cancer and complications of cancer | Oct 24, 2017 | Abandoned |